Related references
Note: Only part of the references are listed.A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1α
Xuelei Wang et al.
EBIOMEDICINE (2020)
Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis
Taiwei Chen et al.
EBIOMEDICINE (2020)
Roles and Mechanisms of Hawthorn and Its Extracts on Atherosclerosis: A Review
Min Wu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice
Min Wu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Quercetin Attenuates Atherosclerosis via Modulating Oxidized LDL-Induced Endothelial Cellular Senescence
Yue-Hua Jiang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Phagocytosis of Wnt inhibitor SFRP4 by late wound macrophages drives chronic Wnt activity for fibrotic skin healing
Denise Gay et al.
SCIENCE ADVANCES (2020)
Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter
Minghui Ou et al.
EBIOMEDICINE (2020)
MD-2 as a possible therapeutic target for atherosclerosis
Shuang Chen et al.
EBIOMEDICINE (2020)
Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas
Alma Zernecke et al.
CIRCULATION RESEARCH (2020)
CoenzymeQ10-Induced Activation of AMPK-YAP-OPA1 Pathway Alleviates Atherosclerosis by Improving Mitochondrial Function, Inhibiting Oxidative Stress and Promoting Energy Metabolism
Tianqi Xie et al.
FRONTIERS IN PHARMACOLOGY (2020)
Role of Endoplasmic Reticulum Stress in Atherosclerosis and Its Potential as a Therapeutic Target
Shengjie Yang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
Chainika Khatana et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Interplay Between Ion Channels and the Wnt/β-Catenin Signaling Pathway in Cancers
Raphael Rapetti-Mauss et al.
FRONTIERS IN PHARMACOLOGY (2020)
Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
Nathalie Niyonzima et al.
EBIOMEDICINE (2020)
Oxidative Storm Induced by Tryptophan Metabolites: Missing Link between Atherosclerosis and Chronic Kidney Disease
Iwona Kwiatkowska et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Oxidative Stress in Ischemic Heart Disease
Aleksandar Kibel et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE-/- Mice
Chuanrui Ma et al.
FRONTIERS IN PHARMACOLOGY (2020)
Knockdown of Sfrp4 attenuates apoptosis to protect against myocardial ischemia/reperfusion injury
Wenhui Zeng et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)
Interleukin-12p35 Deficiency Reverses the Th1/Th2 Imbalance, Aggravates the Th17/Treg Imbalance, and Ameliorates Atherosclerosis in ApoE-/- Mice
Ying Huang et al.
MEDIATORS OF INFLAMMATION (2019)
METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway
Jian Wang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Sebastian Steven et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation
Patricia Marchio et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis
Michelle C. Flynn et al.
FRONTIERS IN PHARMACOLOGY (2019)
FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding
Kai-Chun Cheng et al.
EBIOMEDICINE (2019)
Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases
Nurbubu T. Moldogazieva et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
New insights into the role of iron in inflammation and atherosclerosis
Anne Cornelissen et al.
EBIOMEDICINE (2019)
The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver
Tina Hoerbelt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Single-cell immune landscape of human atherosclerotic plaques
Dawn M. Fernandez et al.
NATURE MEDICINE (2019)
ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis
Xinnong Chen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
MiR-652-3p inhibition enhances endothelial repair and reduces atherosclerosis by promoting Cyclin D2 expression
Rongzhong Huang et al.
EBIOMEDICINE (2019)
Targeting glutaminase 1 attenuates sternness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
Binghua Li et al.
EBIOMEDICINE (2019)
Association between sleep disordered breathing and epigenetic age acceleration: Evidence from the Multi-Ethnic Study of Atherosclerosis
Xiaoyu Li et al.
EBIOMEDICINE (2019)
Secreted frizzled related protein 4 (sFRP4) update: A brief review
Neelam M. Pawar et al.
CELLULAR SIGNALLING (2018)
Macrophage LRP1 Promotes Diet-Induced Hepatic Inflammation and Metabolic Dysfunction by Modulating Wnt Signaling
Dianaly T. Au et al.
MEDIATORS OF INFLAMMATION (2018)
Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis
Smriti Murali Krishna et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain
Vanathi Perumal et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Variants of GSK3β and SFRP4 genes in Wnt signaling were not associated with osteonecrosis of the femoral head
Yang Song et al.
ONCOTARGET (2017)
SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma
Yuen Yee Cheng et al.
DISEASE MARKERS (2017)
Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease
Qingwei Ji et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis
Ulrich Foerstermann et al.
CIRCULATION RESEARCH (2017)
sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease
Sudha Warrier et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Loss of Secreted Frizzled-Related Protein-1 Leads to Deterioration of Cardiac Function in Mice and Plays a Role in Human Cardiomyopathy
Piotr Sklepkiewicz et al.
CIRCULATION-HEART FAILURE (2015)
Loss of SFRP4 Alters Body Size, Food Intake, and Energy Expenditure in Diet-Induced Obese Male Mice
Jason Mastaitis et al.
ENDOCRINOLOGY (2015)
Wnt signaling in atherosclerosis
W. Matthijs Blankesteijn et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Annika Warnatsch et al.
SCIENCE (2015)
Characterization of the Wnt Inhibitors Secreted Frizzled-Related Proteins (SFRPs) in Human Adipose Tissue
Anna Ehrlund et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease
Paola Bovolenta et al.
JOURNAL OF CELL SCIENCE (2008)
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair
Maria Mirotsou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Expression of Tcf/Lef and sFrp and localization of β-catenin in the developing mouse lung
M Tebar et al.
MECHANISMS OF DEVELOPMENT (2001)
Share Paper
